Overview of the Indian CRO market

Overview of the Indian CRO market

The Indian CRO’s have been traditionally “branded” or “out looked” upon as companies involved in regular/routine bioequivalence studies of off patent drugs or involved in/ as SMO’s data management activities. The business of the Indian CRO’s has been since many years a “predictable risk free “model. This model inspired a lot of players to move forward and capitalize on a US $20 Billion outsourcing opportunity with a US $ 17 Billion market for the CRO’s in the developed world.



The Indian CRO market was forecasted to grow beyond a US$ 2 billion market size by the end of 2010. However, with onset of a serious market crisis in the global economy in the year 2008, the market growth was restricted.

http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=335


______________________________________________________________________________________